Sexually transmitted infections in the Netherlands in 2024
R. El-Jobouri, L. Kayaert, M. Visser, D. Sarink, E.L.M. Op de Coul, Z.W. Alexiou, I. van Bergen, A. de Vries, L.E Chanamé Pinedo, K. Bulsink, C. van Bokhoven-Rombouts, J.W. Vanhommerig, A.I. van Sighem, B.H.B. van BenthemRapport
Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021-2022 I-MOVE primary care multicentre study
E. Kissling, F. Pozo, S. Buda, I. Martinez-Baz, S. Buda, A.M. Vilcu, L. Domegan, C. Mazagatos, F. Dijkstra, N. Latorre-Margalef, S.K. Filipović, A. Machado, M. Lazar, I. Casado, R. Dürrwald, S. van der Werf, J. O'Donnell, J.A.L. Dopido, A. Meijer, M. Riess, V.V. Vučina, A.P. Rodrigues, M.E. Mihai, J. Castilla, L. Goerlitz, A. Falchi, J. Connell, D. Castrillejo, M. Hooiveld, A. Carnaha, M. Ilić, R. Guiomar, A. Ivanciuc, M. Maurel, A. Omokanye, M. Valenciano, study I-MOVE teamTijdschriftartikel
